Inhaled corticosteroid use to prevent severe vaso‐occlusive episode recurrence in children between 1 and 4 years of age with sickle cell disease: a multicenter feasibility trial. Issue 4 (5th February 2018) - Vance Utset, Leah; Ivy, Zalaya; Willen, Shaina M.; Rodeghier, Mark; Watt, Amanda; Schilling, Leann; Jenkins, Chantel L.; Pepper, Stefanie; Speller‐Brown, Barbara; Darbari, Deepika S.; Majumdar, Suvankar; Adisa, Olufolake; et al.